Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Catestatin is a peptide derivative of chromogranin A and an inhibitor of norepinephrine release.1 It inhibits nicotine-induced secretion of norepinephrine and nicotine-induced sodium intake in PC12 rat adrenal medulla cells (IC50s = ~0.2 and ~0.25 µM, respectively). Catestatin decreases mean arterial blood pressure and current-induced pressor response and increases plasma levels of epinephrine and histamine in pithed rats.2
WARNING This product is not for human or veterinary use.
1. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J. Clin. Invest. 100(6), 1623-1633 (1997).
2. Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo. Peptides 19(7), 1241-1248 (1998).